Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD : Rationales for “Gibsons’ Conundrum”

Abstract EN

Therapeutic use of carbohydrates in inflammatory bowel diseases (IBDs) is discussed from two theoretical, apparent diametrically opposite perspectives: regular ingestion of prebiotics or withdrawal of virtually all carbohydrate components.

Pathogenesis of IBD is discussed connecting microbial flora, host immunity, and genetic interactions.

The best studied genetic example, NOD2 in Crohn’s disease, is highlighted as a model which encompasses these interactions and has been shown to depend on butyrate for normal function.

The role of these opposing concepts in management of irritable bowel syndrome (IBS) is contrasted with what is known in IBD.

The conclusion reached is that, while both approaches may alleviate symptoms in both IBS and IBD, there is insufficient data yet to determine whether both approaches lead to equivalent bacterial effects in mollifying the immune system.

This is particularly relevant in IBD.

As such, caution is urged to use long-term carbohydrate withdrawal in IBD in remission to control IBS-like symptoms.